Pharmacophore and QSAR modeling of estrogen receptor β ligands and subsequent validation and in silico search for new hits

Molecular Properties That Influence the Oral Bioavailability of Drug Candidates

Daniel F. Veber, Stephen R. Johnson, Hung‐Yuan Cheng et al. · Journal of Medicinal Chemistry · 2002 · 8.1K citations

Pharmacy, Pharmacokinetics, Pharmacology +15

ZINC − A Free Database of Commercially Available Compounds for Virtual Screening

John J. Irwin, Brian K. Shoichet · Journal of Chemical Information and Modeling · 2004 · 4.1K citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +15

Molecular basis of agonism and antagonism in the oestrogen receptor

A.M. Brzozowski, A.C.W. Pike, Zbigniew Dauter et al. · Nature · 1997 · 3.3K citations

Life Sciences, Endocrinology, Pharmacology +14

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites

C. M. Venkatachalam, Xiaoman Jiang, Tom Oldfield et al. · Journal of Molecular Graphics and Modelling · 2002 · 995 citations

Pharmacy, Medicinal Chemistry, Drug Design +10

Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist

A.C.W. Pike · The EMBO Journal · 1999 · 971 citations · Full text

Medicine, Biochemistry, Pharmacology +17